Vadadustat Emerges As Japan HIF-PHI Contender With First Filing Globally

 
• By Ian Haydock

Competition intensifies in novel anemia therapy space in Japan with first filing globally for Akebia/Mitsubishi Tanabe’s contender vadadustat, which could see its first launch worldwide in the country.

RedBloodCellsOnWhite_1200x675
First Filing For Novel Anemia Therapy Vadadustat • Source: Shutterstock

More from Japan

More from Focus On Asia